- Record: found
- Abstract: found
- Article: not found
Early experience with Suboxone maintenance therapy in Hungary.
Zsolt Demetrovics
1 ,
Judit Farkas ,
József Csorba ,
Attila Németh ,
Barbara Mervó ,
János Szemelyácz ,
Enikö Fleischmann ,
Akos Kassai-Farkas ,
Zsolt Petke ,
Tibor Oroján ,
Sándor Rózsa ,
Péter Rigó ,
Sándor Funk ,
Máté Kapitány ,
Anna Kollár ,
József Rácz
Dec 2009
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Suboxone (Buprenorphine/naloxone) is a novel drug used in opiate substitution therapy. In Hungary, it was introduced in November 2007. Suboxone is a product for sublingual administration containing the partial mu-receptor agonist buprenorphine and antagonist naloxone in a 4:1 ratio.